home / stock / ymab / ymab news

YMAB News and Press, Y-mAbs Therapeutics Inc. From 12/21/22

Stock Information
Company Name: Y-mAbs Therapeutics Inc.
Stock Symbol: YMAB
Market: NASDAQ
Menu
YMAB YMAB Quote YMAB Short YMAB News YMAB Articles YMAB Message Board
Get YMAB Alerts

News, Short Squeeze, Breakout and More Instantly...
YMAB - Y-mAbs inks contract with WEP for early access for cancer drug Danyelza in Europe

Y-mAbs Therapeutics ( NASDAQ: YMAB ) said it signed a distribution agreement with WEP Clinical for an early access program for its neuroblastoma drug Danyelza (naxitamab-gqgk) 40mg/10mL Injection in Europe. Neuroblastoma is a cancer which develops from immature nerve cells found i...
YMAB - Y-mAbs Announces Partnership Regarding Early Access Program for DANYELZA (naxitamab-gqgk) in Europe

NEW YORK, Dec. 21, 2022 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a commercial-stage biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatmen...

YMAB - The CHMP has Adopted a Negative Opinion for Omburtamab for the Treatment of CNS/LM Metastasis from Neuroblastoma in Europe

NEW YORK, Dec. 16, 2022 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a commercial-stage biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatmen...

YMAB - Week In Review: Akeso Out-Licenses PD-1/VEGF To Summit In $5 Billion Pact

Summary Chengdu WestGene Biopharma completed a $21 million Series A Round to advance its portfolio of nearly 20 mRNA candidates, including its lead COVID-19 vaccine, which is in IND stage. Suzhou GenAssist Therapeutics raised “millions of dollars” in an A round to support ...
YMAB - Y-mAbs' Danyelza for neuroblastoma gets approval in China

China's National Medical Products Administration granted conditional approval to Y-mAbs Therapeutics' ( NASDAQ: YMAB ) Danyelza to treat neuroblastoma. Neuroblastoma is a cancer which develops from immature nerve cells found in several parts of the body. Danyelza was cond...

YMAB - Y-mAbs' DANYELZA® (naxitamab-gqgk) for the Treatment of High-Risk Neuroblastoma Approved in China

NEW YORK, Dec. 08, 2022 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a commercial-stage biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatmen...

YMAB - 5 Penny Stocks To Buy According To Analysts, Price Targets Up To 919%

5 Penny Stocks To Watch In December With High Marks From Analysts Trading penny stocks has the potential to be a very profitable technique. However, due to the volatility, these trades are seen as having a more significant risk than other types of investments. For individuals seeking to build...
YMAB - Y-mAbs to Host Annual Research and Development Day in New York

NEW YORK, Dec. 06, 2022 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a commercial-stage biopharmaceutical company today announced that it will host its annual Research and Development Day in New York, NY on December 14, 2022,...

YMAB - Y-mAbs Announces Complete Response Letter for Omburtamab Biologics License Application

NEW YORK, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a commercial-stage biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatmen...

YMAB - YMAB INVESTIGATION: Hagens Berman, National Trial Attorneys, Encourages Y-mAbs Therapeutics (YMAB) Investors with Significant Losses to Contact Firm's Attorneys, Firm Investigating Possible Securities Law Violations

SAN FRANCISCO, Nov. 17, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) investors who suffered significant losses to submit your losses now . Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) Investigation: The investigation focuses on Y-...
Previous 10 Next 10